Grandeur Peak Global Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-27,250
Closed -$683K 106
2017
Q2
$683K Sell
27,250
-5,850
-18% -$145K 0.1% 81
2017
Q1
$888K Sell
33,100
-4,750
-13% -$131K 0.15% 78
2016
Q4
$992K Sell
37,850
-4,900
-11% -$121K 0.18% 70
2016
Q3
$1.07M Sell
42,750
-8,725
-17% -$203K 0.21% 70
2016
Q2
$1.12M Sell
51,475
-22,125
-30% -$395K 0.24% 69
2016
Q1
$1.1M Buy
73,600
+4,800
+7% +$80.4K 0.22% 78
2015
Q4
$1.51M Hold
68,800
0.31% 76
2015
Q3
$1.08M Hold
68,800
0.24% 82
2015
Q2
$983K Buy
68,800
+11,375
+20% +$193K 0.19% 86
2015
Q1
$993K Hold
57,425
0.21% 81
2014
Q4
$1.03M Buy
57,425
+6,150
+12% +$99K 0.23% 78
2014
Q3
$673K Buy
51,275
+14,775
+40% +$199K 0.16% 78
2014
Q2
$525K Buy
36,500
+16,500
+83% +$215K 0.11% 89
2014
Q1
$255K Buy
20,000
+14,300
+251% +$187K 0.06% 82
2013
Q4
$57K Buy
5,700
+3,800
+200% +$43.1K 0.02% 105
2013
Q3
$25K Buy
1,900
+1,200
+171% +$15.7K 0.01% 128
2013
Q2
$10K Buy
+700
New +$8.8K ﹤0.01% 111

Other funds holding NXTM

Grandeur Peak Global Advisors's NXTM Position: Q3 2017 in Review

Grandeur Peak Global Advisors sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 27,250 shares — an estimated $683K sold.

Grandeur Peak Global Advisors first reported a position in NXTM in Q2 2013 and held it in 17 quarters. The position peaked at $1.51M in Q4 2015. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Grandeur Peak Global Advisors reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 27,250 NxStage Medical Inc. shares in Q3 2017, an estimated $683K.
  • Grandeur Peak Global Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 17 quarters.
  • Grandeur Peak Global Advisors's NxStage Medical Inc. position peaked at $1.51M in Q4 2015.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.